Document is current
Any future updates will be listed below
-
Authors
Tahtinen, Siri
Tong, Ann-Jay
Himmels, Patricia
Oh, Jaehak https://orcid.org/0000-0003-3079-5927
Paler-Martinez, Andres
Kim, Leesun
Wichner, Sara
Oei, Yoko
McCarron, Mark J.
Freund, Emily C.
Amir, Zhainib Adel
de la Cruz, Cecile C.
Haley, Benjamin
Blanchette, Craig
Schartner, Jill M.
Ye, Weilan https://orcid.org/0000-0002-6219-3982
Yadav, Mahesh
Sahin, Ugur https://orcid.org/0000-0003-0363-1564
Delamarre, Lélia
Mellman, Ira https://orcid.org/0000-0002-6132-7299
- License Information
-
More Information
Article History
Received: 23 November 2021
Accepted: 15 February 2022
First Online: 24 March 2022
Competing interests
: All authors except U.S. are current or former employees of Genentech (South San Francisco, USA). U.S. is a management board member and an employee at BioNTech AG (Mainz, Germany), and inventor on patents and patent applications related to RNA vaccines used in this study. U.S. has securities from BioNTech AG.
Free to read: This content has been made available to all.
